Hassabis: AGI likely within 5 years, with new ideas increasingly decisive
DeepMind's Demis Hassabis argues scaling still pays but frontier advantage is shifting toward algorithmic invention, while real-world bottlenecks like clinical trials and international governance determine how AGI's benefits arrive.